UA
UNWINDAGING // UA-100 DOSSIER
Executive Clinical Surveillance
RECORD: UA-100-2026-JD
TIMESTAMP: 2026-10-25
Subject
JD (Anonymized)
Chronological Age
59.2 Years
Phenotypic Age
51.4 Years (-7.8y)
BMI / Status
25.5 (Overweight)
Supervising Unit
Specialized MD Team
DANGER MEDIOCRE PRE-OPT ELITE
Executive Reserve Telemetry SURGING (+5 vs Baseline)
81 / 100 Pre-Optimal / Approaching Elite

Telemetry confirms clear systemic stabilization: profound iron repletion completed (Ferritin 44 µg/L), glycemic regulation elite (HbA1c 5.2%), and renal filtration recovering (+14 mL/min). The active trajectory has cleared both the danger and mediocre baselines, with 2 targeted watchpoints remaining prior to unlocking sustained Elite Performance.

Top 3 Executive Clinical Priorities
1. Active Arterial Plaque Build-Up & Cardiovascular Defense Critical Focus

Plaque-carrying particles are penetrating arterial walls at an accelerated rate, increasing long-term heart attack and vascular risk.

Telemetry:
ApoB is 138 mg/dL (DANGER ZONE: > 120 mg/dL). Target: < 60 mg/dL.
Action:
Take 1 cap Citrus Bergamot (500mg) + Pomegranate Extract every morning and evening to halt plaque adhesion.
2. Cellular Energy Fatigue & Brain Fog Recovery Orthomolecular Correction

Severe micro-nutrient deficit is undermining cognitive stamina and cellular energy production during high-stress operational cycles.

Telemetry:
RBC Magnesium (4.6 mg/dL) & CoQ10 are suboptimal.
Action:
Take Ubiquinol (200mg) + PQQ (20mg) with breakfast. Take Magnesium L-Threonate (144mg elemental) 30 mins before sleep.
3. Insulin Resistance & Silent Visceral Fat Accumulation Optimized Trajectory

Early protocol execution successfully cleared hepatic lipid accumulation, restoring metabolic flexibility and reducing weight gain drivers.

Telemetry:
Fasting insulin reduced from 8.2 to an optimal 4.1 uIU/mL.
Action:
Maintain a 16:8 fasting window (no calories after 8 PM) and perform 3x 45-minute Zone-2 cardio sessions weekly.
Phenotypic Age Regression Summary
Primary Biological Driver Baseline Score Current Trajectory Clinical Delta Status
DNAm PhenoAge Composite 58.4y 51.4y -7.0y Optimal
Arterial Pulse Wave Velocity (PWV) 8.4 m/s 6.9 m/s -17.8% Optimal
hs-CRP Systemic Inflammatory Index 1.82 mg/L 0.42 mg/L -76.9% Optimal
UA
UNWINDAGING // UA-100 DOSSIER
Multi-Omics Biomarker Surveillance
SUBJECT: JD (59Y)
PANEL: EXPANDED LONGEVITY CORE
Cardiometabolic & Lipid Particle Architecture
Biomarker Standard Reference Executive Longevity Target Patient Result Status
Apolipoprotein B (ApoB) 40 - 100 mg/dL < 60 mg/dL 138 mg/dL Alert
Lipoprotein(a) [Lp(a)] < 75 nmol/L < 30 nmol/L 22 nmol/L Low Risk
LDL Particle Number (LDL-P) 1000 - 1500 nmol/L < 900 nmol/L 840 nmol/L Target Met
High-Sensitivity CRP (hs-CRP) < 2.0 mg/L < 0.50 mg/L 0.38 mg/L Low Inflam
Fasting Insulin 2.6 - 24.9 uIU/mL < 4.5 uIU/mL 3.9 uIU/mL Insulin Sensitive
Homocysteine < 15.0 umol/L < 8.0 umol/L 7.4 umol/L Methylated
Orthomolecular Saturation & Cellular Micronutrition
Biomarker Standard Reference Executive Longevity Target Patient Result Status
RBC Intracellular Magnesium 4.0 - 6.4 mg/dL > 6.2 mg/dL 6.4 mg/dL Replete
Coenzyme Q10 (Plasma Total) 0.5 - 1.8 ug/mL > 3.5 ug/mL 3.8 ug/mL Therapeutic
25-OH Vitamin D3 30 - 100 ng/mL 65 - 85 ng/mL 74 ng/mL Target Met
Omega-3 Index (RBC Membrane) > 4.0 % > 10.0 % 11.2 % Cardioprotective
Methylmalonic Acid (MMA) 87 - 318 nmol/L < 140 nmol/L 115 nmol/L Active B12 Replete
Endocrine Regulation & Systemic Regeneration
Biomarker Standard Reference Executive Longevity Target Patient Result Status
Free Testosterone 35 - 155 pg/mL 120 - 160 pg/mL 142 pg/mL Anabolic Balance
DHEA-Sulfate 80 - 350 ug/dL 250 - 350 ug/dL 290 ug/dL Optimal
IGF-1 (Somatomedin C) 75 - 215 ng/mL 120 - 150 ng/mL 134 ng/mL Calibrated
UA
UNWINDAGING // UA-100 DOSSIER
Phased Intervention & Execution Protocol
PATIENT: JD (59Y)
STATUS: PHASE 2 DEPLOYED
Daily Execution Matrix (Weeks 1 – 12)
Time & Context Protocol / Substrate Action Clinical Objective
MORNING With breakfast & coffee
  • Citrus Bergamot (500 mg)
  • Ubiquinol CoQ10 (200 mg)
  • Pyrroloquinoline Quinone / PQQ (20 mg)
 Clear arterial plaque retention (ApoB). Restore cellular energy and cognitive focus.
EVENING With dinner
  • Citrus Bergamot (500 mg)
  • Pomegranate Polyphenols (Standardized)
 Maintain continuous lipid clearance and protect arterial wall elasticity.
BEDTIME 30 mins prior to sleep
  • Magnesium L-Threonate (144 mg elemental)
  • Buffered Magnesium Taurate (200 mg)
 Cross blood-brain barrier for deep sleep architecture. Regulate nocturnal blood pressure.
LIFESTYLE Continuous adherence
  • 16:8 Fasting Window (No calories after 8 PM)
  • 150 min/wk Zone-2 Cardio (Stationary bike/walk)
 Burn visceral fat stores and sensitize skeletal muscle to insulin.
Executive Coordination & Oversight
Protocol telemetry and daily adherence are facilitated by your Dedicated Wellness Caretaker, with clinical validation and biomarker trajectory reviews directed by a Specialized Preventative MD at 6-week intervals.
Included Enterprise Service

Executive Onboarding Debrief // 30-Minute Protocol Review

Biomarker surveillance is only effective when translated into effortless daily adherence. Your initial UA-100 dossier includes a private, strategic debrief with our Founding Team and Clinical Director.

10 MIN Deconstruct your Top 3 Priorities & sub-clinical risks.
10 MIN Tailor orthomolecular nutrient dosing to your travel schedule.
10 MIN Integrate wearable telemetry and logistics with your Dedicated Wellness Caretaker.
Encrypted Booking: unwindaging.com/debrief
Zero-Knowledge Auth: Reference ID (UA-100-2026-JD) to book via alias.